Approved Therapeutics for NMOSD
First-Ever FDA-Approved Therapies for NMOSD!
After more than 100 years with no approved treatment, today there are four therapeutics for NMOSD which have been regulatory approved in the U.S. and other regions of the world. The Guthy-Jackson Charitable Foundation invites you to learn more about approved therapeutics for NMOSD from industry partners Alexion, Genentech, and Horizon Therapeutics (previously Viela Bio).
We are delighted to offer the latest edition GJCF Pocket Guide to NMOSD Therapeutics. This one of a kind reference is designed to be a user-friendly compass for technical details from clinical, industry, agency and regulatory resources. A practical guide designed for patients and caregivers is coming soon.
